Dissolved and financials
CVR: 39461528
Previous names: Astea Pharma ApS
DKK -215,055
Gross profit
Net result: DKK -807,857
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 7 January 2025
CVR · view overview
1 employee
CVR · 2024
Director role ended: Signe Melhedegård Hansen
CVR · 07/01/2025
View the full event history
CC Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 7 January 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Astea Pharma ApS. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | -215 t. | -808 t. | 504 t. | -7.7 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | -1.6 mio. | -2.7 mio. | 1.6 mio. | -7 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | -910 t. | -2.5 mio. | 3.5 mio. | -4.2 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | 121 t. | -589 t. | 4.6 mio. | -1.7 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | -194 t. | -831 t. | 1 mio. | -1.1 mio. | 1 |
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationNo. CC Pharma Nordic ApS is registered in the Danish CVR register with the status Dissolved and ceased on 7 January 2025.
The CVR number of CC Pharma Nordic ApS is 39461528.
In 2023, CC Pharma Nordic ApS reported a gross profit of DKK -215,055.
CC Pharma Nordic ApS had 1 employee in 2024 according to the Danish CVR register.
CC Pharma Nordic ApS was founded on 3 April 2018.
CC Pharma Nordic ApS was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
As of January 7, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of CC Pharma Nordic ApS.
As of January 7, 2025, Signe Melhedegård Hansen has stepped down as liquidator of CC Pharma Nordic ApS.
On January 7, 2025, CC Pharma Nordic ApS exited liquidation.
CC Pharma Nordic ApS was dissolved on January 7, 2025.
As of September 19, 2024, Steffen Baadsgaard Bruun has left the board of directors of CC Pharma Nordic ApS.
As of September 19, 2024, Signe Melhedegård Hansen is registered as liquidator of CC Pharma Nordic ApS.
As of September 19, 2024, Steffen Baadsgaard Bruun has stepped down as director of CC Pharma Nordic ApS.
As of September 19, 2024, Mathias Bernd Bossen has stepped down as chairman of CC Pharma Nordic ApS.
On September 19, 2024, CC Pharma Nordic ApS entered liquidation.
CC Pharma Nordic ApS has published its annual report for 2023. Gross profit came to DKK -215,055, and the net result was DKK -807,857.
As of November 29, 2023, Bo Tandrup has left the board of directors of CC Pharma Nordic ApS.
As of November 29, 2023, Mathias Bernd Bossen is registered as chairman of CC Pharma Nordic ApS.
As of November 29, 2023, Klaus Herbert Becker has stepped down as chairman of CC Pharma Nordic ApS.
As of June 30, 2023, Alois Schmid has left the board of directors of CC Pharma Nordic ApS.
CC Pharma Nordic ApS has published its annual report for 2022. Gross profit came to DKK -1,634,362, and the net result was DKK -2,730,659.
As of January 23, 2023, Manfred Rolf Ziegler has left the board of directors of CC Pharma Nordic ApS.
CC Pharma Nordic ApS has published its annual report for 2021. Gross profit came to DKK -910,057, and the net result was DKK -2,539,955.
CC Pharma Nordic ApS has published its annual report for 2020. Gross profit came to DKK 121,382, and the net result was DKK -589,254.
As of December 18, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of CC Pharma Nordic ApS.
As of December 18, 2020, EY Danmark A/S has stepped down as auditor of CC Pharma Nordic ApS.
CC Pharma Nordic ApS has published its annual report for 2019. Gross profit came to DKK -194,048, and the net result was DKK -830,910.
CC Pharma Nordic ApS has published its interim report for the period April 3, 2018 to December 31, 2018.
As of March 20, 2019, Bo Tandrup has joined the board of directors of CC Pharma Nordic ApS.
As of March 20, 2019, Klaus Herbert Becker is registered as chairman of CC Pharma Nordic ApS.
As of March 19, 2019, Klaus Herbert Becker has left the board of directors of CC Pharma Nordic ApS.
As of March 19, 2019, Bo Tandrup has stepped down as chairman of CC Pharma Nordic ApS.
On May 17, 2018, the company changed its name from Astea Pharma ApS to CC Pharma Nordic ApS.
As of April 3, 2018, EY Danmark A/S has been appointed auditor of CC Pharma Nordic ApS.
As of April 3, 2018, Steffen Baadsgaard Bruun has joined the board of directors of CC Pharma Nordic ApS.
As of April 3, 2018, Manfred Rolf Ziegler has joined the board of directors of CC Pharma Nordic ApS.
As of April 3, 2018, Alois Schmid has joined the board of directors of CC Pharma Nordic ApS.
As of April 3, 2018, Klaus Herbert Becker has joined the board of directors of CC Pharma Nordic ApS.
As of April 3, 2018, Bo Tandrup is registered as chairman of CC Pharma Nordic ApS.
As of April 3, 2018, Steffen Baadsgaard Bruun is registered as director of CC Pharma Nordic ApS.
CC Pharma Nordic ApS was founded on April 3, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 39371049
CVR 39503778
CVR 40873309
CVR 31774284
CVR 37285145
